Oh, we humans do love a cleanly defined boundary, don’t we? They make things easier, after all. If we’re trying to categorize something, knowing what labeled bin to put it in is handy. If we’re ...

Netherlands-based argenx has published positive topline results from its ADAPT SERON trial of its market-leading drug for generalised myasthenia gravis (gMG) Vyvgart (efgartigimod). Significantly, the ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...